Published in Gene on February 03, 1995
Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother (1996) 10.56
Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother (1996) 8.65
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 4.38
Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 3.26
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob Agents Chemother (1996) 1.88
An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother (2002) 1.79
Complete nucleotide sequence of pSK41: evolution of staphylococcal conjugative multiresistance plasmids. J Bacteriol (1998) 1.74
Regulation of the Bacillus subtilis bcrC bacitracin resistance gene by two extracytoplasmic function sigma factors. J Bacteriol (2002) 1.45
Macrolide efflux in Streptococcus pneumoniae is mediated by a dual efflux pump (mel and mef) and is erythromycin inducible. Antimicrob Agents Chemother (2005) 1.22
Characterization of the Bacillus subtilis ywsC gene, involved in gamma-polyglutamic acid production. J Bacteriol (2002) 1.10
Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections. Infect Immun (2000) 1.07
Detection of macrolide and disinfectant resistance genes in clinical Staphylococcus aureus and coagulase-negative staphylococci. BMC Res Notes (2011) 1.02
Differences in the Enterococcus faecalis lsa locus that influence susceptibility to quinupristin-dalfopristin and clindamycin. Antimicrob Agents Chemother (2005) 0.94
Resistance to bacitracin as modulated by an Escherichia coli homologue of the bacitracin ABC transporter BcrC subunit from Bacillus licheniformis. J Bacteriol (1999) 0.88
Prevalence and mechanism of resistance to antimicrobial agents in group G streptococcal isolates from China. Antimicrob Agents Chemother (2010) 0.77
Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B. Antimicrob Agents Chemother (2013) 0.75
The Macrolide Antibiotic Renaissance. Br J Pharmacol (2017) 0.75
Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol Microbiol (1990) 4.03
Characterisation and molecular cloning of the novel macrolide-streptogramin B resistance determinant from Staphylococcus epidermidis. J Antimicrob Chemother (1989) 2.62
Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol (2002) 2.34
Resistance to arsenic compounds conferred by a plasmid transmissible between strains of Escherichia coli. J Bacteriol (1973) 2.34
Distribution of genes encoding erythromycin ribosomal methylases and an erythromycin efflux pump in epidemiologically distinct groups of staphylococci. J Antimicrob Chemother (1993) 2.25
Antibiotic-resistant acne: lessons from Europe. Br J Dermatol (2003) 2.22
Enzymic basis for a genetic suppression: accumulation and deacylation of N-acetylglutamic gamma-semialdehyde in enterobacterial mutants. Biochim Biophys Acta (1968) 2.19
Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol (2001) 2.14
A variety of gram-positive bacteria carry mobile mef genes. J Antimicrob Chemother (1999) 2.04
16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium. Antimicrob Agents Chemother (1998) 1.94
Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA. Antimicrob Agents Chemother (1997) 1.63
Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol (1990) 1.61
Conjugational behaviour of N plasmids in Escherichia coli K12. Mol Gen Genet (1975) 1.52
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol (1989) 1.40
Arginine hydroxamate-resistant mutants of Bacillus subtilis with altered control of arginine metabolism. J Gen Microbiol (1977) 1.39
Purification and initial characterization of AhrC: the regulator of arginine metabolism genes in Bacillus subtilis. Mol Microbiol (1992) 1.35
Operator interactions by the Bacillus subtilis arginine repressor/activator, AhrC: novel positioning and DNA-mediated assembly of a transcriptional activator at catabolic sites. Mol Microbiol (1997) 1.32
Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother (2001) 1.25
Carbon and nitrogen repression of arginine catabolic enzymes in Bacillus subtilis. J Bacteriol (1979) 1.24
Individually repressible enzymes specified by clustered genes of arginine synthesis. Proc Natl Acad Sci U S A (1965) 1.20
Streptomyces griseus streptomycin phosphotransferase: expression of its gene in Escherichia coli and sequence homology with other antibiotic phosphotransferases and with eukaryotic protein kinases. J Gen Microbiol (1989) 1.20
Sequences required for regulation of arginine biosynthesis promoters are conserved between Bacillus subtilis and Escherichia coli. Mol Microbiol (1989) 1.17
Cloning of a Bacillus subtilis restriction fragment complementing auxotrophic mutants of eight Escherichia coli genes of arginine biosynthesis. Mol Gen Genet (1984) 1.16
Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev (2003) 1.16
Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene (1996) 1.12
Divergent transcription of the argECBH cluster of escherichia coli k12. Mutations which alter the control of enzyme synthesis. J Mol Biol (1976) 1.11
Sequence and transcriptional analysis of the nourseothricin acetyltransferase-encoding gene nat1 from Streptomyces noursei. Gene (1993) 1.08
Expression of the lactose transposon Tn951 in Escherichia coli, Proteus and Pseudomonas. J Gen Microbiol (1980) 1.07
Gene sequence encoding early enzymes of arginine synthesis within a cluster in Bacillus subtilis, as revealed by cloning in Escherichia coli. J Bacteriol (1986) 1.07
Regulation of anaerobic arginine catabolism in Bacillus licheniformis by a protein of the Crp/Fnr family. FEMS Microbiol Lett (2000) 1.07
Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and -resistant skin bacteria from acne patients. Br J Dermatol (1994) 1.07
Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol (1992) 1.06
MutS binding protects heteroduplex DNA from exonuclease digestion in vitro: a simple method for detecting mutations. Nucleic Acids Res (1994) 1.05
Map locations of some mutations conferring resistance to arginine hydroxamate in Bacillus subtilis 168. Mol Gen Genet (1980) 1.05
Nucleotide sequence of a Bacillus subtilis arginine regulatory gene and homology of its product to the Escherichia coli arginine repressor. Gene (1989) 1.04
A binding site for activation by the Bacillus subtilis AhrC protein, a repressor/activator of arginine metabolism. Mol Gen Genet (1995) 1.03
Molecular detection of streptomycin-producing streptomycetes in Brazilian soils. Appl Environ Microbiol (1997) 1.03
Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ (1993) 1.01
Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother (1996) 1.00
Dissecting the molecular details of prokaryotic transcriptional control by surface plasmon resonance: the methionine and arginine repressor proteins. Biosens Bioelectron (1998) 0.98
Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology (1998) 0.97
Temporal changes in sebum excretion and propionibacterial colonization in preadolescent children with and without acne. Br J Dermatol (2007) 0.95
Reduced recovery of plasmid transconjugants in crosses with Escherichia coli rho mutant recipients. Plasmid (1977) 0.94
Multiple mechanisms of erythromycin resistance. J Antimicrob Chemother (1990) 0.94
Cloning and expression in Escherichia coli of a Streptomyces coelicolor A3(2) argCJB gene cluster. Microbiology (1994) 0.94
ABC proteins and antibiotic drug resistance: is it all about transport? Biochem Soc Trans (2005) 0.92
Transcription analysis of a Bacillus subtilis arg gene following cloning in Escherichia coli in an initially unstable hybrid plasmid. Mol Gen Genet (1984) 0.92
Absence of polar effect of frameshift mutations in the E gene of the Escherichia coli argECBH cluster. J Gen Microbiol (1971) 0.92
Salmonella typhimurium strain LT-2 is still pathogenic for man. J Gen Microbiol (1971) 0.91
Skin carriage of antibiotic-resistant coagulase-negative staphylococci in untreated subjects. J Antimicrob Chemother (1990) 0.91
Cloning in Escherichia coli of a Bacillus subtilis arginine repressor gene through its ability to confer structural stability on a fragment carrying genes of arginine biosynthesis. Mol Gen Genet (1986) 0.91
Acetylhistidine as substrate for acetylornithinase: a new system for the selection of arginine regulation mutants in Escherichia coli. Mol Gen Genet (1970) 0.91
Sequence analysis of the Bacillus subtilis argC promoter region. Gene (1986) 0.90
The effect of benzoyl peroxide on cutaneous micro-organisms in vitro. J Appl Bacteriol (1983) 0.90
A note on a selective medium for the isolation of cutaneous propionibacteria. J Appl Bacteriol (1982) 0.90
Macrolide-lincosamide-streptogramin B (MLS) resistance in cutaneous propionibacteria: definition of phenotypes. J Antimicrob Chemother (1989) 0.89
Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol (2003) 0.88
Effects of oxygen concentration on biomass production, maximum specific growth rate and extracellular enzyme production by three species of cutaneous propionibacteria grown in continuous culture. J Gen Microbiol (1983) 0.88
Implication of a repression system, homologous to those of other bacteria, in the control of arginine biosynthesis genes in Streptomyces coelicolor. Mol Gen Genet (1996) 0.87
Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline. Br J Dermatol (1993) 0.87
Bacillus subtilis 168 mutants resistant to arginine hydroxamate in the presence of ornithine or citrulline. J Gen Microbiol (1984) 0.87
Cytolysin gene expression in Enterococcus faecalis is regulated in response to aerobiosis conditions. Mol Genet Genomics (2003) 0.86
Benefit-risk assessment of acne therapies. Lancet (1997) 0.86
Active membrane transport and receptor proteins from bacteria. Biochem Soc Trans (2005) 0.86
Cloning, characterization and expression in Escherichia coli of a leucine biosynthetic gene from Streptomyces rochei. J Gen Microbiol (1987) 0.85
Probing activation of the prokaryotic arginine transcriptional regulator using chimeric proteins. J Mol Biol (1999) 0.85
Variation in expression of sex factor genes in the Proteus-Providencia group relative to Escherichia coli. J Bacteriol (1975) 0.85
Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol (1988) 0.85
Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technol Assess (2005) 0.84
Plasmid effects on secondary metabolite production by a streptomycete synthesizing an anthelmintic macrolide. J Gen Microbiol (1991) 0.84
The arginine operon of Bacillus stearothermophilus: characterization of the control region and its interaction with the heterologous B. subtilis arginine repressor. Mol Gen Genet (1996) 0.84
Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol (1983) 0.84
Propionibacterium acnes and acne. Dermatology (1998) 0.83
Toxic shock syndrome: the effect of solid phase materials on the physiology of Staphylococcus aureus. Postgrad Med J (1985) 0.83
Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol (2005) 0.82
Topical antibiotic therapy: current status and future prospects. Drugs Exp Clin Res (1990) 0.82
Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions. J Med Microbiol (1979) 0.81